NASDAQ:CLVS
Delisted

Clovis Oncology Stock News

etoro logo Buy CLVS
*Your capital is at risk
$0.151
+0 (+0%)
At Close: Apr 19, 2023
Equities research analysts expect that Clovis Oncology (NASDAQ:CLVS) will announce sales of $42.80 million for the current quarter, according to Zacks Investment Research. Four analysts have issued es
Clovis Oncology (NASDAQ:CLVS) was upgraded by equities researchers at BidaskClub from a “sell” rating to a “hold” rating in a report released on Tuesday, BidAskClub reports. Other analysts hav
Brokerages forecast that Clovis Oncology (NASDAQ:CLVS) will post earnings of ($1.27) per share for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimat

90 Biggest Movers From Friday

12:00am, Monday, 30'th Mar 2020
So far Saturday, March 28, NASDAQ is down -1.28% and the S&P is up 0.15%. Let’s take a look at
So far Friday, March 27, NASDAQ is up 1.48% and the S&P is up 1.28%. Here are this morning’s most

Clovis: Coronavirus Bear Market Overreaction

09:59pm, Thursday, 26'th Mar 2020
In the middle of difficulty is an opportunity. The coronavirus bear market knocked down Clovis shares far beyond their true worth. For the 4Q2019 earnings repor
Clovis (CLVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Clovis (CLVS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE